118 related articles for article (PubMed ID: 7823572)
1. Lymphokine-activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma.
Arinaga S; Karimine N; Nanbara S; Inoue H; Nakashima H; Ueo H; Akiyoshi T
J Surg Oncol; 1995 Jan; 58(1):44-9. PubMed ID: 7823572
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients.
Karimine N; Arinaga S; Inoue H; Nanbara S; Ueo H; Akiyoshi T
Clin Exp Immunol; 1994 Jun; 96(3):484-90. PubMed ID: 8004819
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients.
Karimine N; Nanbara S; Arinaga S; Asoh T; Ueo H; Akiyoshi T
J Surg Oncol; 1994 Mar; 55(3):179-85. PubMed ID: 8176929
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.
Koba F; Akiyoshi T; Arinaga S; Wada T; Tsuji H
Jpn J Surg; 1987 Mar; 17(2):83-90. PubMed ID: 2957537
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
6. Activated killer cell activity in lymph nodes.
Akiyoshi T; Koba F; Tsuji H
J Clin Lab Immunol; 1987 Feb; 22(2):91-5. PubMed ID: 3496459
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
[TBL] [Abstract][Full Text] [Related]
8. [Study of adoptive immunotherapy with lymphokine-activated killer (LAK) cells and interleukin-2 for metastatic renal cell carcinoma. I. Generation of LAK cells by incubation in serum-free medium].
Nomura K; Fujioka T
Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):822-30. PubMed ID: 8320887
[TBL] [Abstract][Full Text] [Related]
9. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
Hermann GG; Petersen KR; Steven K; Zeuthen J
J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.
Ebihara T; Fukao K; Koyama S
Cancer; 1990 Sep; 66(5):923-9. PubMed ID: 2167147
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha.
Chong AS; Ybarrondo B; Grimes WJ; Hersh EM; Scuderi P
Cancer Immunol Immunother; 1990; 31(4):255-9. PubMed ID: 2143102
[TBL] [Abstract][Full Text] [Related]
12. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes of patients with gastric carcinoma.
Koba F; Akiyoshi T; Tsuji H
J Clin Lab Immunol; 1987 Apr; 22(4):181-4. PubMed ID: 3497276
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
Chong AS; Boussy IA; Graf LH; Scuderi P
Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634
[TBL] [Abstract][Full Text] [Related]
14. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
Koba F; Akiyoshi T; Tsuji H
J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
[TBL] [Abstract][Full Text] [Related]
16. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
17. Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.
Logan TF; Gooding WE; Whiteside TL; Ernstoff MS; Kaplan SS; Miketic L; Vlock DR; Tompkins C; Wood DL; Nadler PI; Kirkwood JM
J Immunother; 1997 Sep; 20(5):387-98. PubMed ID: 9336746
[TBL] [Abstract][Full Text] [Related]
18. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.
Koyama S; Ebihara T; Fukao K; Osuga T
Jpn J Cancer Res; 1989 Feb; 80(2):150-7. PubMed ID: 2498249
[TBL] [Abstract][Full Text] [Related]
20. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
